Evaluation of a Digital Visual Acuity Device vs. Standard Visual Acuity Measurements
ConditionVisual Acuity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic
About this trial
The purpose of this research is to validate and determine the accuracy of the experimental device when measuring visual acuity versus our standard visual acuity measurements and to gather voice recordings of letters to help build a special system that recognizes spoken letters.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult patients (≥ 18 years) who come to Ophthalmology Clinic.
Willing and able to provide consent.
Disqualifiers
Individuals < 18 years of age.
Unable to provide consent.
Trial design
Design model
Single group
Treatments tested in this trial
FaceScan
DeviceDigital visual acuity device built for iOS ("iPhone") that conducts an assessment of visual acuity using a combination of integrated light detection and ranging (LiDAR) and voice processing.
Treatment groups
150 Participants
are divided into 1 treatment groupGroup A: Digital Visual Acuity TestExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Number of times the experimental device when measuring visual acuity agreed with standard visual acuity measurements
Number of subjects to have agreement between the visual acuity digital device and the clinical assessment
Time frame
BaselineSecondary outcomes
1
Voice samples
Total number of voice samples collected of spoken letters
Time frame
BaselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: